Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Human T-cell leukemia virus 1 infection 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬Human T-cell leukemia virus 1 infection
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 2 | Human T-cell leukemia virus 1 infection 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬Human T-cell leukemia virus 1 infection
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 3 | IgSF CAM signaling 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬IgSF CAM signaling
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 4 | IgSF CAM signaling 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬IgSF CAM signaling
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 5 | Natural killer cell mediated cytotoxicity 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬Natural killer cell mediated cytotoxicity
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 6 | Natural killer cell mediated cytotoxicity 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬Natural killer cell mediated cytotoxicity
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 7 | NF-kappa B signaling pathway 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬NF-kappa B signaling pathway
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 8 | NF-kappa B signaling pathway 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬NF-kappa B signaling pathway
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 9 | Osteoclast differentiation 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬Osteoclast differentiation
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 10 | Osteoclast differentiation 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬Osteoclast differentiation
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 11 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 12 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 13 | Primary immunodeficiency 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬Primary immunodeficiency
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 14 | Primary immunodeficiency 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬Primary immunodeficiency
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 15 | T cell receptor signaling pathway 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬T cell receptor signaling pathway
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 16 | T cell receptor signaling pathway 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬T cell receptor signaling pathway
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 17 | Th1 and Th2 cell differentiation 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬Th1 and Th2 cell differentiation
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 18 | Th1 and Th2 cell differentiation 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬Th1 and Th2 cell differentiation
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 19 | Th17 cell differentiation 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬Th17 cell differentiation
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 20 | Th17 cell differentiation 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬Th17 cell differentiation
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 21 | Yersinia infection 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬Yersinia infection
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
||||||||||||||||
| 22 | Yersinia infection 💬 1 gene, 1 drug (DrugBank) and 3 diseases |
LCK [1] LCK 💬Human T-cell leukemia virus 1 infection
|
Dasatinib Dasatinib 💬Yersinia infection
| Dasatinib | 013 [3] 13, 51, 85 💬1. Human T-cell leukemia virus 1 infection
|
Human T-cell leukemia virus 1 infection
1 gene, 1 drug (DrugBank) and 3 diseases
IgSF CAM signaling
1 gene, 1 drug (DrugBank) and 3 diseases
Natural killer cell mediated cytotoxicity
1 gene, 1 drug (DrugBank) and 3 diseases
NF-kappa B signaling pathway
1 gene, 1 drug (DrugBank) and 3 diseases
Osteoclast differentiation
1 gene, 1 drug (DrugBank) and 3 diseases
PD-L1 expression and PD-1 checkpoint pathway in cancer
1 gene, 1 drug (DrugBank) and 3 diseases
Primary immunodeficiency
1 gene, 1 drug (DrugBank) and 3 diseases
T cell receptor signaling pathway
1 gene, 1 drug (DrugBank) and 3 diseases
Th1 and Th2 cell differentiation
1 gene, 1 drug (DrugBank) and 3 diseases
Th17 cell differentiation
1 gene, 1 drug (DrugBank) and 3 diseases
Yersinia infection
1 gene, 1 drug (DrugBank) and 3 diseases